Activity Stream
@moatrx
• one week ago
Posted a new blog:
US MYASTHENIA GRAVIS LAUNCH READINESS
US MYASTHENIA GRAVIS LAUNCH READINESS
A new gMG agent must address FcRn-inadequate responders or claim a serostatus niche efgartigimod's dominance has left open.
Efgartigimod (Vyvgart/Vyvgart Hytrulo)...



